1. Home
  2. ICD-10-CM Codes
  3. G00–G99
  4. G70-G73
  5. G71
  6. 2024 ICD-10-CM Code G71.29
Version 2024
Billable Code

2024 ICD-10-CM Diagnosis Code G71.29

Other congenital myopathy

ICD-10-CM Code:
G71.29
ICD-10 Code for:
Other congenital myopathy
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Diseases of the nervous system
    (G00–G99)
    • Diseases of myoneural junction and muscle
      (G70-G73)
      • Primary disorders of muscles
        (G71)

G71.29 is a billable diagnosis code used to specify a medical diagnosis of other congenital myopathy. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Actin accumulation myopathy
  • Akinesia
  • Antenatal multi-minicore disease with arthrogryposis multiplex congenita
  • Autosomal dominant central core disease
  • Autosomal dominant congenital fiber-type disproportion myopathy due to ACTA1 mutation
  • Autosomal dominant congenital fiber-type disproportion myopathy due to SELENON mutation
  • Autosomal dominant congenital fiber-type disproportion myopathy due to TPM3 mutation
  • Autosomal recessive central core disease
  • Autosomal recessive congenital fiber-type disproportion myopathy due to ACTA1 mutation
  • Autosomal recessive congenital fiber-type disproportion myopathy due to SELENON mutation
  • Autosomal recessive congenital fiber-type disproportion myopathy due to TPM3 mutation
  • Benign congenital myopathy
  • Benign Samaritan congenital myopathy
  • Bethlem myopathy
  • Cap myopathy
  • Central core disease
  • Congenital articular rigidity with myopathy
  • Congenital fiber-type disproportion myopathy due to ACTA1 mutation
  • Congenital fiber-type disproportion myopathy due to ACTA1 mutation
  • Congenital fiber-type disproportion myopathy due to ACTA1 mutation
  • Congenital fiber-type disproportion myopathy due to MYH7 mutation
  • Congenital fiber-type disproportion myopathy due to SELENON mutation
  • Congenital fiber-type disproportion myopathy due to TPM3 mutation
  • Congenital fiber-type disproportion myopathy due to ZAK mutation
  • Congenital generalized hypercontractile muscle stiffness syndrome
  • Congenital lethal myopathy Compton North type
  • Congenital multi-minicore disease with external ophthalmoplegia
  • Congenital myopathy with abnormal subcellular organelles
  • Congenital myopathy with fiber type disproportion
  • Congenital myopathy with internal nuclei and atypical cores
  • Congenital myopathy with myasthenic-like onset
  • Congenital myopathy with reduced type 2 muscle fibers
  • Congenital myopathy with uniform fiber type
  • Congenital nonprogressive myopathy with Moebius and Robin sequences
  • Cylindrical spirals myopathy
  • Desmin related myopathy with Mallory body-like inclusions
  • Desmin-related myofibrillar myopathy
  • Duane anomaly, myopathy, scoliosis syndrome
  • Duane's syndrome, type 3
  • Early-onset myopathy, areflexia, respiratory distress, dysphagia syndrome
  • Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia
  • Intellectual disability, cataract, calcified pinna, myopathy syndrome
  • Intellectual disability, myopathy, short stature, endocrine defect syndrome
  • Multi-core congenital myopathy
  • Multi-core congenital myopathy
  • Multi-core congenital myopathy
  • Muscle filaminopathy
  • Myopathy with abnormality of histochemical fiber type
  • Myopathy with cytoplasmic inclusions
  • Myopathy with cytoplasmic inclusions
  • Myopathy with hexagonally cross-linked tubular arrays
  • Myopathy with tubular aggregates
  • Myopathy with type I hypotrophy
  • Myosclerosis
  • Myosin storage myopathy
  • Nemaline myopathy
  • Nemaline myopathy, early onset type
  • Pinnal calcification
  • Proximal myopathy
  • Reducing-body myopathy
  • Sarcotubular myopathy
  • Zebra body myopathy

Clinical Classification

Clinical Information

  • Akinesia

    lack of movement.

  • Fetal Akinesia Deformation Sequence|FADS|Pena-Shokeir syndrome, Type 1

    a condition characterized by fetal akinesia and intrauterine growth restriction, that may be associated with mutation(s) in the rapsn or dok7 genes, encoding 43 kda receptor-associated protein of the synapse and protein dok-7, respectively.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Central core disease
  • Minicore disease
  • Multicore disease
  • Multiminicore disease

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Replacement Code

G7129 replaces the following previously assigned ICD-10-CM code(s):

  • G71.2 - Congenital myopathies

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - Code Added, effective from 10/1/2020 through 9/30/2021

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.